Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

University of Delaware's Mona Batish is a molecular biologist. She studies circular RNAs formed as a result of so-called ...

Located unusually early in the protein sequence, the stop codon would be ... This normally requires a specific signal in the mRNA that guides the ribosome to override the stop and insert ...

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

Located unusually early in the protein sequence, the stop codon would be expected to end ... This normally requires a specific signal in the mRNA that guides the ribosome to override the stop and ...

Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between ...

RT-PCR and sequencing revealed a small amount of normal-size mRNA with normal exon 1-exon 2 splicing. Quantitative RT-PCR on mutant LMSF showed AR mRNA levels were well below 10% of normal ...

Once the mRNA is released, the cellular machinery reads the mRNA sequence and produces and expresses the characteristic spike protein, allowing the body’s immune system to train itself to combat ...